SurvivorNet

What are oncologists asking about patient care?

The questions clinicians bring to SurvivorNet’s MHQ: Clinical Intelligence give us a clearer picture of where they’re looking for more guidance. Built on proprietary technology that’s earned 14 U.S. patents, the platform lets clinicians ask questions and hear directly from their peers. Expert videos and links to the evidence are built right into the answer.

See how it works, then try it out yourself: snconnect.survivornet.com/mhq-clinical-i…

The first conversation with your doctor is a chance to understand what comes next—but it's hard to know what questions to ask.

@BCMCancerCenter's Dr. Jacob Mandel walks #Glioma patients through what to expect in that first conversation with their doctor, how to know what to ask next, and why your questions deserve time.
Take a look below, then bring your questions to My Health Questions for help preparing for your next appointment.

survivornet.com/my-health-ques…

How does SurvivorNet help oncologists continue to make better decisions for patients? For advanced prostate cancer, our orientation is to work with the most respected experts to help explain complex topics and then weave this material into our proprietary AI models for doctors and patients.

In this case, @MSKCancerCenter's Dr. Michael Morris, U.S. principal investigator of #PSMAddition, walks through his current parameters for #radioligandtherapy and patient selection, especially earlier in the disease course.

Try our tool for doctors here: snconnect.survivornet.com/mhq-clinical-i…

Now, on its 14th patent, SurvivorNet’s AI platform, My Health Questions, is already bringing the conversations from #ESMO 2026 directly to patients. Patients are asking questions, and our expert videos are integrated directly into the answers—helping patients understand what these latest developments mean for their care.

survivornet.com/my-health-ques…

One of the great unmet needs in #oncology, and there are many, has been small-cell lung cancer, but finally, there's progress.
At #ESMO26, @DanaFarber's Dr. @sands_jacob joined us, speaking directly to physicians about the phase 3 #DeLLphi305 trial and what this new data could mean for patients.

Explore more of SurvivorNet’s #ESMO coverage below: survivornet.com/articles/new-d…